APA (7th ed.) Citation

C, P., QV, W., J, V., JJ, H., B, B., N, F., . . . CP, R. (2023). Neutrophil to lymphocyte ratio and peripheral blood biomarkers correlate with survival outcomes but not response among head and neck and salivary cancer treated with pembrolizumab and vorinostat. Head & neck, 45(2), 391. https://doi.org/10.1002/hed.27252

Chicago Style (17th ed.) Citation

C, Pan, et al. "Neutrophil to Lymphocyte Ratio and Peripheral Blood Biomarkers Correlate with Survival Outcomes but Not Response Among Head and Neck and Salivary Cancer Treated with Pembrolizumab and Vorinostat." Head & Neck 45, no. 2 (2023): 391. https://doi.org/10.1002/hed.27252.

MLA (9th ed.) Citation

C, Pan, et al. "Neutrophil to Lymphocyte Ratio and Peripheral Blood Biomarkers Correlate with Survival Outcomes but Not Response Among Head and Neck and Salivary Cancer Treated with Pembrolizumab and Vorinostat." Head & Neck, vol. 45, no. 2, 2023, p. 391, https://doi.org/10.1002/hed.27252.